载有伐卢比星的免疫脂质体靶向免疫抑制细胞上的抗原,以规避癌症免疫治疗的耐药性 Valrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy. PubMed 2026/02/27 发表Cell Rep MedQ1 · IF 14(JCR 2025) 靶点:VEGFR技术:NK 细胞肺癌淋巴瘤地区:欧洲